Biodegradation of chiral pharmaceuticals by an activated sludge consortium followed by a Chiral HPLC-FD
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2012 |
| Outros Autores: | , , |
| Idioma: | eng |
| Título da fonte: | Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
| Texto Completo: | http://hdl.handle.net/10400.14/13238 |
Resumo: | Biodegradation tends to be enantioselective in contrast to abiotic degradation and it is necessary enantioselective analytical methods to quantify the enantiomeric fraction of chiral pharmaceuticals in the environment for correct risk assessment. In this work, we developed HPLC-FD methods to follow the biodegradation of four beta-blockers: alprenolol , propranolol , metoprolol and atenolol and the antidepressant fluoxetine during 15 days in batch mode. The biodegradation assays were performed using AS from the aerated tanks of a municipal wastewater treatment plant with a singly compound supplementation and a mixture compound supplementation similar to those found in wastewater influents. Abiotic degradation in the presence of light and in the dark was evaluated. Either the low concentration or the mixture effects are situations closer to those found in the environment. The results indicate the higher degradation extents for the S-enantiomer forms, as is shown in Figure 1. |
| id |
RCAP_a27d8244dd146351ad155a7f84ea6d36 |
|---|---|
| oai_identifier_str |
oai:repositorio.ucp.pt:10400.14/13238 |
| network_acronym_str |
RCAP |
| network_name_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
| repository_id_str |
https://opendoar.ac.uk/repository/7160 |
| spelling |
Biodegradation of chiral pharmaceuticals by an activated sludge consortium followed by a Chiral HPLC-FDbiodegradationchiralpharmaceuticalsBiodegradation tends to be enantioselective in contrast to abiotic degradation and it is necessary enantioselective analytical methods to quantify the enantiomeric fraction of chiral pharmaceuticals in the environment for correct risk assessment. In this work, we developed HPLC-FD methods to follow the biodegradation of four beta-blockers: alprenolol , propranolol , metoprolol and atenolol and the antidepressant fluoxetine during 15 days in batch mode. The biodegradation assays were performed using AS from the aerated tanks of a municipal wastewater treatment plant with a singly compound supplementation and a mixture compound supplementation similar to those found in wastewater influents. Abiotic degradation in the presence of light and in the dark was evaluated. Either the low concentration or the mixture effects are situations closer to those found in the environment. The results indicate the higher degradation extents for the S-enantiomer forms, as is shown in Figure 1.VeritatiRibeiro, Ana R.Castro, P. M. L.Afonso, CarlosTiritan, Maria2013-11-14T15:40:31Z2012-032012-03-01T00:00:00Zconference objectinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/10400.14/13238enginfo:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-03-13T12:47:12Zoai:repositorio.ucp.pt:10400.14/13238Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-29T01:51:44.281250Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse |
| dc.title.none.fl_str_mv |
Biodegradation of chiral pharmaceuticals by an activated sludge consortium followed by a Chiral HPLC-FD |
| title |
Biodegradation of chiral pharmaceuticals by an activated sludge consortium followed by a Chiral HPLC-FD |
| spellingShingle |
Biodegradation of chiral pharmaceuticals by an activated sludge consortium followed by a Chiral HPLC-FD Ribeiro, Ana R. biodegradation chiral pharmaceuticals |
| title_short |
Biodegradation of chiral pharmaceuticals by an activated sludge consortium followed by a Chiral HPLC-FD |
| title_full |
Biodegradation of chiral pharmaceuticals by an activated sludge consortium followed by a Chiral HPLC-FD |
| title_fullStr |
Biodegradation of chiral pharmaceuticals by an activated sludge consortium followed by a Chiral HPLC-FD |
| title_full_unstemmed |
Biodegradation of chiral pharmaceuticals by an activated sludge consortium followed by a Chiral HPLC-FD |
| title_sort |
Biodegradation of chiral pharmaceuticals by an activated sludge consortium followed by a Chiral HPLC-FD |
| author |
Ribeiro, Ana R. |
| author_facet |
Ribeiro, Ana R. Castro, P. M. L. Afonso, Carlos Tiritan, Maria |
| author_role |
author |
| author2 |
Castro, P. M. L. Afonso, Carlos Tiritan, Maria |
| author2_role |
author author author |
| dc.contributor.none.fl_str_mv |
Veritati |
| dc.contributor.author.fl_str_mv |
Ribeiro, Ana R. Castro, P. M. L. Afonso, Carlos Tiritan, Maria |
| dc.subject.por.fl_str_mv |
biodegradation chiral pharmaceuticals |
| topic |
biodegradation chiral pharmaceuticals |
| description |
Biodegradation tends to be enantioselective in contrast to abiotic degradation and it is necessary enantioselective analytical methods to quantify the enantiomeric fraction of chiral pharmaceuticals in the environment for correct risk assessment. In this work, we developed HPLC-FD methods to follow the biodegradation of four beta-blockers: alprenolol , propranolol , metoprolol and atenolol and the antidepressant fluoxetine during 15 days in batch mode. The biodegradation assays were performed using AS from the aerated tanks of a municipal wastewater treatment plant with a singly compound supplementation and a mixture compound supplementation similar to those found in wastewater influents. Abiotic degradation in the presence of light and in the dark was evaluated. Either the low concentration or the mixture effects are situations closer to those found in the environment. The results indicate the higher degradation extents for the S-enantiomer forms, as is shown in Figure 1. |
| publishDate |
2012 |
| dc.date.none.fl_str_mv |
2012-03 2012-03-01T00:00:00Z 2013-11-14T15:40:31Z |
| dc.type.driver.fl_str_mv |
conference object |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| status_str |
publishedVersion |
| dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.14/13238 |
| url |
http://hdl.handle.net/10400.14/13238 |
| dc.language.iso.fl_str_mv |
eng |
| language |
eng |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.source.none.fl_str_mv |
reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia instacron:RCAAP |
| instname_str |
FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
| instacron_str |
RCAAP |
| institution |
RCAAP |
| reponame_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
| collection |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
| repository.name.fl_str_mv |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
| repository.mail.fl_str_mv |
info@rcaap.pt |
| _version_ |
1833601147326169088 |